We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

106 hedge funds and large institutions have $700M invested in Assembly Biosciences in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 23

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

56% more capital invested

Capital invested by funds: $449M → $700M (+$251M)

8% more funds holding

Funds holding: 98 → 106 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.09% less ownership

Funds ownership: 7.73% → 7.64% (-0.09%)

Holders
106
Holders Change
+8
Holders Change %
+8.16%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
49
Reduced
23
Closed
8
Calls
$542K
Puts
–
Net Calls
+$542K
Net Calls Change
+$1.31M

Top Buyers

1
EC
EcoR1 Capital
California
+$10.9M
2
State Street
State Street
Massachusetts
+$9.29M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$6.86M
4
BlackRock
BlackRock
New York
+$4.8M
5
MWNA
Marshall Wace North America
New York
+$3.06M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$32.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.98M
3
Morgan Stanley
Morgan Stanley
New York
-$2.82M
4
AC
Armistice Capital
New York
-$2.49M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Consonance Capital Management
New York
$74.1M – – –
EC
2
EcoR1 Capital
California
$73.5M +$10.9M +46,926 +22%
BlackRock
3
BlackRock
New York
$59.3M +$4.8M +20,583 +11%
Jennison Associates
4
Jennison Associates
New York
$54.9M +$242K +1,037 +0.5%
Vanguard Group
5
Vanguard Group
Pennsylvania
$36.9M +$1.89M +8,116 +7%
BBA
6
Baker Bros. Advisors
New York
$36M – – –
RSCM
7
Rock Springs Capital Management
Maryland
$35M -$21K -90 -0.1%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$32.6M -$776K -3,325 -3%
Citadel Advisors
9
Citadel Advisors
Florida
$27.1M +$737K +3,160 +3%
State Street
10
State Street
Massachusetts
$24M +$9.29M +39,838 +87%
Victory Capital Management
11
Victory Capital Management
Texas
$21.4M -$32.9M -140,862 -65%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$15.9M -$1.09M -4,665 -8%
SAM
13
Sectoral Asset Management
Quebec, Canada
$15.3M +$926K +3,969 +8%
Franklin Resources
14
Franklin Resources
California
$15M – – –
AC
15
Armistice Capital
New York
$13.9M -$2.49M -10,666 -18%
BCPEMI
16
Bain Capital Public Equity Management II
Massachusetts
$12.1M +$6.86M +29,413 +211%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$12M +$263K +1,129 +3%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$10.4M +$622K +2,666 +8%
EA
19
Emerald Advisers
Pennsylvania
$10.3M +$93.8K +402 +1%
N
20
Nuveen
North Carolina
$10M -$1.4M -5,999 -14%
Northern Trust
21
Northern Trust
Illinois
$9.85M +$982K +4,211 +14%
MWNA
22
Marshall Wace North America
New York
$8.35M +$3.06M +13,128 +79%
EMFAT
23
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.03M +$429K +1,839 +7%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$7.51M -$4.98M -21,357 -44%
Axa
25
Axa
France
$5.06M +$209K +897 +5%
1
2 3 4 5

ASMB Hedge Fund Activity: Q2 2020 in Review

106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2020, worth a combined $700M — up 56% from $449M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ASMB positions and 8 closed out — a net gain of 8 holders — while 49 added to existing stakes and 23 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $10.9M. The largest seller was Victory Capital Management, cutting an estimated $32.9M.

  • 106 institutional investors held Assembly Biosciences (ASMB) as of Q2 2020, up from 98 in Q1 2020.
  • Funds reported $700M of Assembly Biosciences stock for Q2 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Assembly Biosciences positions in Q2 2020 and 8 closed out, a net change of +8 holders.
  • The largest Assembly Biosciences buyer in Q2 2020 was EcoR1 Capital, an estimated $10.9M added.
  • The largest Assembly Biosciences seller in Q2 2020 was Victory Capital Management, an estimated $32.9M sold.

Based on aggregated 13F filings for Q2 2020.